Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View.
Oprea-Lager DE, van Elst T, Aluwini S, Dewulf E, der Poel HV, Stoevelaar H, Bangma CH, Beeker A, Boudewijns S, Budiharto T, de Jong IJ, de Vries KC, Donswijk ML, Fütterer JJ, Hamberg P, Heijmen L, Hoekstra RJ, Kerkhofs TMA, Lavalaye J, Bruin DL, Noordzij W, Oving IM, Robbrecht DGJ, Schaake EE, van de Luijtgaarden ACM, van den Bergh RCN, van den Berkmortel F, van der Hulle T, van der Mijn JCK, van Dodewaard-de Jong JM, van Kruchten M, van Leeuwen PJ, van Limbergen E, van Moorselaar RJA, van Oort IM, van Roermund JGH, van Soest RJ, Veninga T, Vis AN, Voortman J, Willemse PM, Yakar D, Mehra N. Oprea-Lager DE, et al. Among authors: donswijk ml. Eur Urol Open Sci. 2025 Apr 7;75:69-79. doi: 10.1016/j.euros.2025.03.007. eCollection 2025 May. Eur Urol Open Sci. 2025. PMID: 40256661 Free PMC article.
Gallium-68-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.
van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L. van Leeuwen PJ, et al. BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7. BJU Int. 2019. PMID: 30074667
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
Luiting HB, van Leeuwen PJ, Busstra MB, Brabander T, van der Poel HG, Donswijk ML, Vis AN, Emmett L, Stricker PD, Roobol MJ. Luiting HB, et al. Among authors: donswijk ml. BJU Int. 2020 Feb;125(2):206-214. doi: 10.1111/bju.14944. Epub 2019 Nov 29. BJU Int. 2020. PMID: 31680398 Free PMC article. Review.
Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection.
Huits TH, Luiting HB, van der Poel HG, Nandurkar R, Donswijk M, Schaake E, Vogel W, Roobol MJ, Wit E, Stricker P, Emmett L, van Leeuwen PJ. Huits TH, et al. BJU Int. 2020 Jun;125(6):876-883. doi: 10.1111/bju.15052. Epub 2020 Apr 23. BJU Int. 2020. PMID: 32181951 Free PMC article.
Reply by Authors.
Luiting HB, van Leeuwen PJ, Remmers S, Donswijk M, Busstra MB, Bakker IL, Brabander T, Stokkel M, van der Poel HG, Roobol MJ. Luiting HB, et al. J Urol. 2020 Sep;204(3):510. doi: 10.1097/JU.0000000000001012.02. Epub 2020 Jun 26. J Urol. 2020. PMID: 32589489 No abstract available.
103 results